E. Blair

发表

Response-adapted volume de-escalation (RAVD) in locally advanced head and neck cancer.

E. Vokes, T. Seiwert, D. Haraf, 2016, Annals of oncology : official journal of the European Society for Medical Oncology.

Salivary glands sarcoidosis

E. Blair, V. Rao, J. Curran, 2008 .

Integrative and Comparative Genomic Analysis of HPV-Positive and HPV-Negative Head and Neck Squamous Cell Carcinomas

Petar Stojanov, Kevin P. White, Christopher D. Brown, 2014, Clinical Cancer Research.

A phase II study of lapatinib (GW572016) in recurrent/metastatic (R/M) squamous cell carcinoma of the head and neck (SCCHN).

J. Dancey, E. Vokes, E. Cohen, 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Head and neck cancer. The problem.

E. Blair, D. Callender, 1994, Clinics in plastic surgery.

Mucoepidermoid Carcinoma

A. Pearson, N. Cipriani, M. Lingen, 2019, The American journal of surgical pathology.

Board 438 - Research Abstract The Use of Simulation to Teach Professionalism in Graduate Medical Education: A Systematic Review of the Literature (Submission #908)

Angela D. Blood, S. Small, Eisha Wali, 2013 .

Large tracheoesophageal granular cell tumor: An atypical case presentation, location, and management

N. Cipriani, E. Blair, Ashley Diaz, 2022, International journal of surgery case reports.

WHIM syndrome and oral squamous cell carcinoma.

N. Cipriani, E. Blair, J. Taxy, 2010, Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics.

Optima: A phase II dose and volume de-escalation trial for high- and low-risk HPV+ oropharynx cancers.

E. Vokes, T. Seiwert, D. Haraf, 2017 .

Efficacy and safety of treating T4 oral cavity tumors with primary chemoradiotherapy

R. Weichselbaum, E. Vokes, D. Huo, 2009, Head & neck.

Lymph node density—Prognostic value in head and neck cancer

D. Haraf, K. Stenson, E. Blair, 2014, Head & neck.

Final Results of a Randomized Phase 2 Trial Investigating the Addition of Cetuximab to Induction Chemotherapy and Accelerated or Hyperfractionated Chemoradiation for Locoregionally Advanced Head and Neck Cancer.

E. Vokes, T. Seiwert, D. Haraf, 2016, International journal of radiation oncology, biology, physics.

Characterizing Lymph Node Burden With Elective Unilateral Neck Irradiation in Human Papillomavirus-Positive Tonsil Squamous Cell Carcinoma: Defining the Upper Limits

A. Pearson, E. Vokes, D. Haraf, 2022, Cureus.

A randomized phase II trial of cetuximab-based induction chemotherapy followed by concurrent cetuximab, 5-FU, hydroxyurea, and hyperfractionated radiation (CetuxFHX), or cetuximab, cisplatin, and accelerated radiation with concomitant boost (CetuxPX) in patients with locoregionally advanced head and

E. Vokes, T. Seiwert, D. Haraf, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

OPTIMA: a phase II dose and volume de-escalation trial for human papillomavirus-positive oropharyngeal cancer.

E. Vokes, T. Seiwert, D. Haraf, 2019, Annals of Oncology.

Prior chemoradiotherapy adversely impacts outcomes of recurrent and second primary head and neck cancer treated with concurrent chemotherapy and reirradiation

E. Vokes, T. Seiwert, K. Choe, 2011, Cancer.

Seeding with endothelial cells derived from the microvessels of the omentum and from the jugular vein: a comparative study.

A. Sterpetti, R. Schultz, J. Valentine, 1988, Journal of vascular surgery.

Concurrent Chemotherapy and Intensity-Modulated Radiotherapy for Organ Preservation of Locoregionally Advanced Oral Cavity Cancer

E. Vokes, D. Haraf, K. Stenson, 2011, American journal of clinical oncology.

Chemoradiation for patients with advanced oral cavity cancer

E. Vokes, D. Haraf, E. Cohen, 2009, The Laryngoscope.

Adjuvant chemotherapy prior to postoperative concurrent chemoradiotherapy for locoregionally advanced head and neck cancer.

E. Vokes, K. Choe, D. Haraf, 2010, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

The minor salivary gland biopsy as a diagnostic tool for Sjogren syndrome

E. Blair, A. Langerman, N. Sweiss, 2009, The Laryngoscope.

Utility of Lip Biopsy in the Diagnosis and Treatment of Sjogren's Syndrome

E. Blair, A. Langerman, N. Sweiss, 2007, The Laryngoscope.

Adjuvant chemoradiotherapy for locoregionally advanced and high-risk salivary gland malignancies

E. Vokes, T. Seiwert, D. Haraf, 2011, Head & neck oncology.

Chemoradiotherapy for locoregionally advanced squamous cell carcinoma of the base of tongue

E. Vokes, D. Haraf, K. Stenson, 2010, Head & neck.

Identification of abdominal aortic aneurysm patients with different clinical features and clinical outcomes.

A. Sterpetti, R. Schultz, R. J. Feldhaus, 1988, American journal of surgery.

Erratum: ERRATUM: OPTIMA: a phase II dose and volume de-escalation trial for human papillomavirus-positive oropharyngeal cancer (Ann Oncol (2019) DOI: 10.1093/annonc/mdy522)

E. Vokes, T. Seiwert, D. Haraf, 2019 .

Outcomes of induction chemotherapy followed by concurrent chemoradiation for nasopharyngeal carcinoma.

E. Vokes, D. Haraf, E. Cohen, 2013, Oral oncology.

Malignant Skin Neoplasms and Associated Conditions

N. Cipriani, D. Ginat, E. Blair, 2018, Neuroradiological Imaging of Skin Diseases and Related Conditions.

Outcomes of Induction Chemotherapy and Concurrent Chemoradiation for Nasopharyngeal Carcinoma

E. Vokes, D. Haraf, E. Cohen, 2012 .

Sealed rupture of abdominal aortic aneurysms.

A. Sterpetti, R. Schultz, R. J. Feldhaus, 1990, Journal of vascular surgery.

Chemoreirradiation for recurrent salivary gland malignancies.

E. Vokes, D. Haraf, K. Stenson, 2010, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Planned Post‐Chemoradiation Neck Dissection: Significance of Radiation Dose

E. Vokes, A. Argiris, D. Huo, 2006, The Laryngoscope.

Labial minor salivary gland biopsy

E. Blair, A. Langerman, 2008 .

Salivary Gland Secretory Carcinoma With High-Grade Transformation, CDKN2A/B Loss, Distant Metastasis, and Lack of Sustained Response to Crizotinib

N. Cipriani, D. Ginat, V. Villaflor, 2017, International journal of surgical pathology.

Upper airway complications of smoking.

E. Blair, T. Fitzpatrick, 2000, Clinics in chest medicine.

OPTIMA: a phase II dose and volume de-escalation trial for human papillomavirus-positive oropharyngeal cancer

E. Vokes, T. Seiwert, D. Haraf, 2019, Annals of oncology : official journal of the European Society for Medical Oncology.

Erlotinib and the Risk of Oral Cancer: The Erlotinib Prevention of Oral Cancer (EPOC) Randomized Clinical Trial.

Edward S. Kim, S. Lippman, I. Wistuba, 2016, JAMA oncology.

Nasal Cavity Tumefactive Fibroinflammatory Lesion Mimicking Recurrent Mucoepidermoid Carcinoma

D. Ginat, E. Blair, 2017, Ear, nose, & throat journal.

Erlotinib and bevacizumab in patients with recurrent or metastatic squamous-cell carcinoma of the head and neck: a phase I/II study.

J. Dancey, E. Vokes, T. Seiwert, 2009, The Lancet. Oncology.

Comparison of outcomes of locoregionally advanced oropharyngeal and non-oropharyngeal squamous cell carcinoma over two decades.

E. Vokes, T. Seiwert, D. Haraf, 2015, Annals of oncology : official journal of the European Society for Medical Oncology.

Dose and Volume De-Escalation for Human Papillomavirus-Positive Oropharyngeal Cancer is Associated with Favorable Post-Treatment Functional Outcomes.

E. Vokes, T. Seiwert, D. Haraf, 2020, International journal of radiation oncology, biology, physics.

Plerixafor for the Treatment of WHIM Syndrome

S. Pittaluga, E. Landon, C. Buck, 2019, The New England journal of medicine.

A phase I dose escalation study of Ad GV.EGR.TNF.11D (TNFerade™ Biologic) with concurrent chemoradiotherapy in patients with recurrent head and neck cancer undergoing reirradiation.

R. Weichselbaum, E. Vokes, T. Seiwert, 2013, Annals of oncology : official journal of the European Society for Medical Oncology.

Airway management before chemoradiation for advanced head and neck cancer

E. Cohen, K. Stenson, E. Blair, 2012, Head & neck.

Deep learning prediction of BRAF-RAS gene expression signature identifies noninvasive follicular thyroid neoplasms with papillary-like nuclear features

A. Pearson, N. Cipriani, N. Agrawal, 2020, Modern Pathology.

Characteristics associated with swallowing changes after concurrent chemotherapy and radiotherapy in patients with head and neck cancer.

E. Vokes, L. Mell, D. Haraf, 2008, Archives of otolaryngology--head & neck surgery.

Definitive chemoradiation for locally-advanced oral cavity cancer: A 20-year experience.

E. Vokes, T. Seiwert, D. Haraf, 2018, Oral oncology.

Effect of topical antibiotic therapy on recovery after tonsillectomy in adults

E. Blair, E. Mann, Audrey S. Chang, 1999, Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery.

A Phase II Study of Lapatinib in Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck

Jeffrey Bozeman, J. Dancey, E. Vokes, 2012, Clinical Cancer Research.

Cost analysis of antibiotic prophylaxis in clean head and neck surgery.

J. Johnson, E. Blair, R. Wagner, 1995, Archives of otolaryngology--head & neck surgery.

Epidermal growth factor receptor inhibitor gefitinib added to chemoradiotherapy in locally advanced head and neck cancer.

Olufunmilayo I. Olopade, Mark W. Lingen, Everett E. Vokes, 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Complete Radiographic Response Correlates With Pathologic Complete Response in Locoregionally Advanced Head and Neck Cancer

E. Vokes, D. Haraf, K. Stenson, 2015 .

Performance and quality of life outcomes for T4 laryngeal cancer patients treated with induction chemotherapy followed by chemoradiotherapy.

E. Vokes, K. Mouw, D. Haraf, 2012, Oral oncology.

Neck response to chemoradiotherapy: complete radiographic response correlates with pathologic complete response in locoregionally advanced head and neck cancer.

E. Vokes, D. Haraf, K. Stenson, 2009, Archives of otolaryngology--head & neck surgery.

Nivolumab, nabpaclitaxel, and carboplatin followed by risk/response adaptive de-escalated locoregional therapy for HPV-associated oropharyngeal cancer: OPTIMA II trial.

A. Pearson, E. Vokes, T. Seiwert, 2021 .

Factors associated with long-term speech and swallowing outcomes after chemoradiotherapy for locoregionally advanced head and neck cancer.

Xi Xi, Joseph K Salama, E. Vokes, 2010, Archives of otolaryngology--head & neck surgery.

Aneurysmal Bone Cyst of the Maxillary Sinus with USP6 Rearrangement: Case Report of a Rare Entity and Review of the Literature

N. Cipriani, J. Collins, E. Blair, 2018, Head and Neck Pathology.

A randomized phase II study of 5-fluorouracil, hydroxyurea, and twice-daily radiotherapy compared with bevacizumab plus 5-fluorouracil, hydroxyurea, and twice-daily radiotherapy for intermediate-stage and T4N0-1 head and neck cancers.

E. Vokes, D. Haraf, K. Stenson, 2011, Annals of oncology : official journal of the European Society for Medical Oncology.

A Phase I Trial of Docetaxel Based Induction and Concomitant Chemotherapy in Patients with Locally Advanced Head and Neck Cancer

E. Vokes, T. Seiwert, D. Haraf, 2007, Cancer investigation.

A phase I trial of aminolevulinic acid-photodynamic therapy for treatment of oral leukoplakia.

E. Szabo, E. Cohen, R. Bergan, 2013, Oral oncology.

Phase II study of gefitinib adaptive dose escalation to skin toxicity in recurrent or metastatic squamous cell carcinoma of the head and neck.

O. Olopade, E. Vokes, T. Seiwert, 2012, Oral Oncology.

Emergency airway management: Training and experience of chief residents in otolaryngology and anesthesiology

J. Pinto, E. Blair, James D. Andrews, 2012 .

OPTIMA—A Phase 2 Trial of Induction Chemotherapy Response-Stratified Radiation Therapy Dose and Volume De-escalation for HPV+ Oropharyngeal Cancer: Efficacy, Toxicity, and HPV Subtype Analysis

E. Vokes, T. Seiwert, D. Haraf, 2018 .

Teaching professionalism in graduate medical education: What is the role of simulation?

Angela D. Blood, S. Small, Eisha Wali, 2016, Surgery.

Medical comorbidities for paradoxical vocal fold motion (vocal cord dysfunction) in the military population.

Matthew J. Makashay, N. Solomon, E. Blair, 2010, Journal of voice : official journal of the Voice Foundation.

Phase II trial of pemetrexed-based induction chemotherapy followed by concomitant chemoradiotherapy in previously irradiated patients with squamous cell carcinoma of the head and neck.

E. Vokes, D. Haraf, E. Cohen, 2011, Annals of oncology : official journal of the European Society for Medical Oncology.

Multi-disciplinary management of patients with benign airway strictures: A review.

S. Murgu, E. Blair, A. Agrawal, 2021, Respiratory medicine.

Minor salivary gland inflammation in Devic’s disease and longitudinally extensive myelitis

A. Reder, B. Arnason, T. Kelly, 2008, Multiple sclerosis.

Integrative and Comparative Genomic Analysis of HPV-Positive and HPV-Negative Head and Neck Squamous Cell Carcinomas

Christopher D. Brown, Trevor J Pugh, G. Getz, 2014, Clinical Cancer Research.

Assessment of Tumor Burden and Response by RECIST vs. Volume Change in HPV+ Oropharyngeal Cancer – An Exploratory Analysis of Prospective Trials

E. Vokes, D. Haraf, E. Izumchenko, 2022, International Journal of Radiation Oncology*Biology*Physics.

Headache with Unilateral Pulsatile Tinnitus in Women Can Signal Dural Sinus Thrombosis

E. Blair, M. Redleaf, Farhad Sigari, 2006, The Annals of otology, rhinology, and laryngology.

OPTIMA: a phase II dose and volume de-escalation trial for human papillomavirus-positive oropharyngeal cancer.

E. Vokes, T. Seiwert, D. Haraf, 2019, Annals of oncology : official journal of the European Society for Medical Oncology.

A phase I dose escalation study of Ad GV.EGR.TNF.11D (TNFerade™ Biologic) with concurrent chemoradiotherapy in patients with recurrent head and neck cancer undergoing reirradiation.

E. Vokes, D. Haraf, M. Lingen, 2013, Annals of oncology : official journal of the European Society for Medical Oncology.

Response-adapted volume de-escalation (RAVD) of radiotherapy (RT) using induction chemotherapy (IC) in locally advanced head and neck squamous cell cancer (LA-HNSCC).

E. Vokes, D. Haraf, K. Stenson, 2015 .